Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M425Revenue $M3.6Net Margin (%)-159.3Z-Score9.7
Enterprise Value $M310EPS $-0.4Operating Margin %-200.9F-Score5
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-151.8Higher ROA y-yY
Price/Book4.410-y EBITDA Growth Rate %-3.8Quick Ratio17.2Cash flow > EarningsN
Price/Sales50.55-y EBITDA Growth Rate %16.0Current Ratio17.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-15.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-21.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M39.5ROI % (ttm)-71.8Gross Margin Increase y-yY

Gurus Latest Trades with CGEN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CGEN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

CGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about CGEN :

    Quarterly/Annual Reports about CGEN:

      News about CGEN:

      Articles On GuruFocus.com
      creiter note on CGEN Jan 03 2010 
      Compugen Reports Second Quarter 2009 Results Jul 28 2009 
      Compugen Ltd. Reports Fourth Quarter and Year-End 2008 Financial Results Feb 11 2009 
      Compugen Ltd. to Review Fourth Quarter and Year-End 2008 Financial Results on Wednesday, February 11 Feb 04 2009 

      More From Other Websites
      7:05 am Compugen announces presentations of results for CGEN-15001 supporting immune tolerance... Sep 29 2014
      Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction Sep 29 2014
      Can The Uptrend Continue for Compugen (CGEN)? Sep 05 2014
      Compugen (CGEN): Strong Industry, Solid Earnings Estimate Revisions Sep 04 2014
      Compugen Appoints Mr. Ari Krashin as Chief Financial Officer Aug 25 2014
      Compugen Reacquires Baize’s Financial Interest in Pipeline Product Candidates Aug 21 2014
      Compugen Ltd. Reports 2nd Quarter 2014 Financial Results Aug 06 2014
      CORRECTED DATE FOR Q2 CONFERENCE CALL: Compugen Second Quarter 2014 Conference Call Scheduled for... Jul 31 2014
      Compugen Second Quarter 2014 Conference Call Scheduled for Tuesday, August 5, 2014 at 10:00 AM EDT Jul 29 2014
      Compugen to Present Immune Checkpoint Related Research at Two Scientific Conferences Jul 24 2014
      Compugen jumps after announcing newly discovered proteins Jul 14 2014
      Compugen Extends Discovery Capabilities to Additional Immunomodulatory Proteins Jul 14 2014
      Compugen shares rise on news of positive cancer collaboration with Bayer Jul 07 2014
      Compugen Discloses Achievement of Milestone in Cancer Immunotherapy Collaboration with Bayer Jul 07 2014
      Will Compugen (CGEN) Continue to Surge Higher? Jun 19 2014
      Compugen Discloses Experimental Results for Novel Checkpoint Candidate for Cancer Immunotherapy and... Jun 16 2014
      Compugen's (CGEN) CEO Dr. Anat Cohen-Dayag on Q1 2014 Results - Earnings Call Transcript May 19 2014
      Compugen says South San Francisco unit to move to larger facilities May 19 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial